10.000
+4,17%
2026-10-19
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +39.5% | -31.2% | 1 / 3 | +82.3% | -3.60 pp | -0.57 pp | +8.3% | 0.64 | 10.87 | 162 | +82,3% | 9,3 | +65,7% | 10.87 | 11.76 | −7,6% |
| Pts | 8 | 0 | 4 | 12 | 0 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 10.000 (close price on 2026-10-19)EPS (TTM): 920,3
Financial charts
1.Revenue & growth
VND bn162Q2/26
1.Revenue & growth
VND bn162Q2/26
2.Profit & growth
VND bn9,27Q2/26
3.Profit mix (Penman)
VND bn21,7Q2/26
4.Margins & cost structure
%15.0%Q2/26
5.Returns & cash cycle
% · days7.6%Q2/26
6.Earnings quality & cash
VND bn9,43Q2/26
7.Asset structure
VND bn483Q2/26
8.Funding & debt health
VND bn · times483Q2/26
9.Revenue backlog
VND bn16,2Q2/26
10.Valuation
times · %11,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %407Q2/26
Adjusted EPS growth, latest quarter
49.3%
Average adjusted EPS growth, 3 quarters
-30.2%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q2/26